Literature DB >> 22170499

Role of the mu-opioid receptor in opioid modulation of immune function.

Jana Ninković1, Sabita Roy.   

Abstract

Endogenous opioids are synthesized in vivo to modulate pain mechanisms and inflammatory pathways. Endogenous and exogenous opioids mediate analgesia in response to painful stimuli by binding to opioid receptors on neuronal cells. However, wide distribution of opioid receptors on tissues and organ systems outside the CNS, such as the cells of the immune system, indicate that opioids are capable of exerting additional effects in the periphery, such as immunomodulation. The increased prevalence of infections in opioid abuser-based epidemiological studies further highlights the immunosuppressive effects of opioids. In spite of their many debilitating side effects, prescription opioids remain a gold standard for treatment of chronic pain. Therefore, given the prevalence of opioid use and abuse, opioid-mediated immune suppression presents a serious concern in our society today. It is imperative to understand the mechanisms by which exogenous opioids modulate immune processes. In this review, we will discuss the role of opioid receptors and their ligands in mediating immune-suppressive functions. We will summarize recent studies on direct and indirect opioid modulation of the cells of the immune system, as well as the role of opioids in exacerbation of certain disease states.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170499      PMCID: PMC3912755          DOI: 10.1007/s00726-011-1163-0

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  136 in total

1.  Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure.

Authors:  Ana M Lugo-Chinchilla; Dennise Báez; Mariella Vélez; Cristhian Ildefonso; Fernando L Renaud
Journal:  J Neuroimmunol       Date:  2006-06-05       Impact factor: 3.478

Review 2.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

3.  Effects of a glyconutrient on macrophage functions.

Authors:  D L Lefkowitz; R Stuart; B T Gnade; E Roberts; S S Lefkowitz
Journal:  Int J Immunopharmacol       Date:  2000-04

4.  Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages.

Authors:  M Sedqi; S Roy; S Ramakrishnan; R Elde; H H Loh
Journal:  Biochem Biophys Res Commun       Date:  1995-04-17       Impact factor: 3.575

Review 5.  Mechanisms of morphine-induced immunomodulation.

Authors:  P K Peterson; T W Molitor; C C Chao
Journal:  Biochem Pharmacol       Date:  1993-08-03       Impact factor: 5.858

6.  Suppression of human peripheral blood mononuclear cell function by methadone and morphine.

Authors:  P K Peterson; G Gekker; C Brummitt; P Pentel; M Bullock; M Simpson; J Hitt; B Sharp
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

7.  Stereospecific opiate binding in living human polymorphonuclear leucocytes.

Authors:  N E Falke; E G Fischer; R Martin
Journal:  Cell Biol Int Rep       Date:  1985-11

Review 8.  Opiate inhibition of chemokine-induced chemotaxis.

Authors:  M C Grimm; A Ben-Baruch; D D Taub; O M Howard; J M Wang; J J Oppenheim
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

9.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

10.  Morphine pellet-induced immunomodulation in mice: temporal relationships.

Authors:  H U Bryant; E W Bernton; J W Holaday
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

View more
  47 in total

1.  Opioid treatment of experimental pain activates nuclear factor-κB.

Authors:  Peggy Compton; Charles Griffis; Elizabeth Crabb Breen; Matthew Torrington; Ryan Sadakane; Eshetu Tefera; Michael R Irwin
Journal:  J Opioid Manag       Date:  2015 Mar-Apr

Review 2.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

Review 3.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

Review 4.  The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.

Authors:  Ryan A Mischel; Karan H Muchhala; William L Dewey; Hamid I Akbarali
Journal:  J Pain       Date:  2019-12-11       Impact factor: 5.820

Review 5.  [Perioperative inflammation].

Authors:  J Rossaint; A Margraf; A Zarbock
Journal:  Anaesthesist       Date:  2019-07       Impact factor: 1.041

6.  Exposure to Early Life Pain: Long Term Consequences and Contributing Mechanisms.

Authors:  Nicole C Victoria; Anne Z Murphy
Journal:  Curr Opin Behav Sci       Date:  2016-02

7.  Dorsal hippocampal neural immune signaling regulates heroin-conditioned immunomodulation but not heroin-conditioned place preference.

Authors:  Jacqueline E Paniccia; Christina L Lebonville; Meghan E Jones; Shveta V Parekh; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2018-07-31       Impact factor: 7.217

8.  The effect of morphine upon DNA methylation in ten regions of the rat brain.

Authors:  Timothy M Barrow; Hyang-Min Byun; Xinyan Li; Chris Smart; Yong-Xiang Wang; Yacong Zhang; Andrea A Baccarelli; Liqiong Guo
Journal:  Epigenetics       Date:  2018-01-22       Impact factor: 4.528

9.  Electroacupuncture Attenuates Surgical Stress-Induced Reduction of T Lymphocytes through Modulation of Peripheral Opioid System.

Authors:  Ke Wang; Yue Yong; Jia Zhou; Wen-Xiong Zhou; Jun Guo; Tong-Yu Chen
Journal:  Chin J Integr Med       Date:  2020-09-26       Impact factor: 1.978

10.  The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.

Authors:  E J Edelman; K S Gordon; J P Tate; W C Becker; K Bryant; K Crothers; J R Gaither; C L Gibert; A J Gordon; Bdl Marshall; M C Rodriguez-Barradas; J H Samet; M Skanderson; A C Justice; D A Fiellin
Journal:  HIV Med       Date:  2016-11       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.